GERON CORP
A biopharma company developing a telomerase inhibitor for hematologic malignancies.
GERN | US
Overview
Corporate Details
- ISIN(s):
- US3741631036
- LEI:
- Country:
- United States of America
- Address:
- 919 EAST HILLSDALE BOULEVARD, 94404 FOSTER CITY
- Website:
- https://www.geron.com/
- Sector:
- Manufacturing
Description
Geron Corp is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for hematologic malignancies. Its lead product, imetelstat, is a first-in-class telomerase inhibitor approved for the treatment of certain blood cancers. The company's scientific approach targets telomerase to alter the course of hematologic myeloid malignancies, with the goal of extending and enhancing the lives of patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-02 19:20 |
8-K
|
English | 197.7 KB | ||
| 2023-05-11 23:01 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.0 KB | ||
| 2023-05-11 19:01 | English | 6.7 KB | |||
| 2023-05-11 10:11 |
8-K
|
English | 103.5 KB | ||
| 2023-05-11 09:50 |
10-Q
|
English | 1.7 MB | ||
| 2023-05-01 23:20 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 7.3 KB | ||
| 2023-05-01 17:53 | English | 6.9 KB | |||
| 2023-04-20 19:26 |
ARS
|
English | 26.0 MB | ||
| 2023-04-20 11:30 |
8-K
|
English | 770.6 KB | ||
| 2023-04-14 08:30 |
DEFA14A
|
English | 4.0 MB | ||
| 2023-04-12 19:25 |
DEFA14A
|
English | 4.0 MB | ||
| 2023-04-12 19:21 |
DEF 14A
|
English | 1.3 MB | ||
| 2023-04-03 22:47 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.9 KB | ||
| 2023-04-03 22:46 |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
English | 6.8 KB | ||
| 2023-03-31 19:20 |
PRE 14A
|
English | 594.1 KB |
Automate Your Workflow. Get a real-time feed of all GERON CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GERON CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GERON CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
